Arjun Balar
Medical Oncology · New York, NYNPI 1558528273
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $119,253 of the $148,926 with a category attached, or 80.1%. 16 manufacturers reported payments, led by Merck at 50.2% of the total. Reporting peaked in 2019 at $57,099 and has fallen 98.2% since, to $1,028 in 2022.
Across 87 payments — averaging $1711.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$75K
- Seagen Inc.$27K
- GSK$17K
- Genentech, Inc.$8K
- AstraZeneca$4K
- E.r. Squibb & Sons, L.L.C.$4K
- plus $15K from 10 others
Across 639 payments — averaging $9362.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$3.8M
- Seagen Inc.$1.3M
- Genentech, Inc.$301K
- AbbVie$180K
- E.r. Squibb & Sons, L.L.C.$162K
- Clovis Oncology, Inc.$55K
- plus $136K from 6 others
What the payments were for
- Consulting fees$119,25380%
- Speaking & faculty fees$12,7949%
- Travel & lodging$14,72810%
- Food & beverage$2,1411%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 35 | $74,818 |
| Seagen Inc. | 21 | $26,591 |
| GSK | 4 | $16,575 |
| Genentech, Inc. | 5 | $8,006 |
| AstraZeneca | 3 | $4,305 |
| E.r. Squibb & Sons, L.L.C. | 2 | $3,802 |
| Pfizer | 2 | $3,647 |
| F. Hoffmann-la Roche AG | 3 | $2,922 |
| Astellas Pharma Global Development | 1 | $2,500 |
| Janssen Research & Development, LLC | 1 | $1,620 |
| Eli Lilly | 1 | $1,400 |
| Gilead | 1 | $1,400 |
| Immunomedics, Inc. | 2 | $1,050 |
| Genentech USA, Inc. | 4 | $258 |
| Johnson & Johnson | 1 | $17 |
| Boston Scientific | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$148,926 in reported general payments places this provider in the 85th percentile of 498 medical oncology providers in New York.
Other medical oncology in New York
- Craig ThompsonNew York$4.8M
- Andrew SeidmanNew York$1.3M
- Joshua RichterNew York$971K
- Edward GelmannNew York$944K
- Ghassan Abou-AlfaNew York$825K
- Miguel PeralesNew York$769K
- Komal JhaveriNew York$642K
- Joshua BrodyNew York$492K
- Aiwu HeNew York$445K
- Raajit RampalNew York$418K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.